Fibriant awarded Euro 16.5M EIC Accelerator funding to support RECOFIB development

Leiden, The Netherlands, 23 December 2021 – Fibriant, a scale-up biotech company focused onthe development of the RECOFIB platform, was [...]

By | December 29th, 2021|Geen categorie|0 Comments

Fibriant expands license adding recombinant human (pro)thrombin to existing recombinant fibrinogen capability – Company on track for clinical studies with RecoSeelTM in mild-to-moderate bleeding in 2021

Leiden, The Netherlands, December 5, 2019 - Fibriant B.V., a developer of innovative recombinant fibrin(ogen) technology and products, today announced [...]

By | December 5th, 2019|Geen categorie|0 Comments

Fibriant CEO Jaap Koopman to present at the 11th annual Biotech Showcase event 2019 on January 7 at 4.30 PM in the Hilton San Francisco Union Square in San Francisco, CA, USA.

Fibriant will provide an up-date on the progress with the development of their recombinant Fibrinogen technology platform and the product [...]

By | January 3rd, 2019|Geen categorie|0 Comments

Presentation by Prof. Matthew Flick at the 25th International Fibrinogen Research Society meeting in Winston-Salem, NC, USA.

Prof. Flick, a leader in the field of Fibrinogen and host-defense, will present, also on behalf of Fibriant, new data [...]

By | June 5th, 2018|Geen categorie|0 Comments

Fibriant and Biomed Elements announce collaboration to develop a new topical hemostat product to stop severe bleeding supported by a MIT grant from the province of Zuid Holland, The Netherlands.

Fibriant and Biomed Elements have entered into a research collaboration, combining their fibrinogen and biopolymer technologies, to develop a topical [...]

By | January 5th, 2017|Geen categorie|0 Comments
Load More Posts